Zura Bio Completes Merger with Liminal BioSciences
Ticker: ZURA · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1855644
| Field | Detail |
|---|---|
| Company | Zura Bio Ltd (ZURA) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: merger, acquisition, reorganization
TL;DR
Zura Bio and Liminal BioSciences are now one company, trading as ZURA on Nasdaq.
AI Summary
Zura Bio Ltd. announced on February 24, 2025, the closing of its previously announced business combination with Liminal BioSciences Inc. This transaction resulted in the combined entity being renamed Zura Bio Ltd. and will trade under the ticker symbol "ZURA" on the Nasdaq Capital Market.
Why It Matters
The merger creates a larger, combined entity focused on developing novel therapies, potentially accelerating drug development and market entry.
Risk Assessment
Risk Level: medium — Mergers and acquisitions inherently carry integration risks, regulatory hurdles, and potential market reception uncertainties.
Key Players & Entities
- Zura Bio Ltd. (company) — Registrant and combined entity
- Liminal BioSciences Inc. (company) — Company merged with Zura Bio
- Nasdaq Capital Market (company) — Exchange where the combined entity will trade
FAQ
What is the new ticker symbol for the combined company?
The combined company will trade under the ticker symbol "ZURA" on the Nasdaq Capital Market.
When did the business combination officially close?
The business combination closed on February 24, 2025.
What was the former name of the company before the merger?
The filing indicates a former company name of JATT Acquisition Corp, with a name change date of 20210407, though the primary focus of this 8-K is the merger with Liminal BioSciences.
Where is Zura Bio Ltd. incorporated?
Zura Bio Ltd. is incorporated in the Cayman Islands.
What is the primary business of Zura Bio Ltd. according to the SIC code?
The Standard Industrial Classification code indicates Zura Bio Ltd. is in the business of Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding Zura Bio Ltd (ZURA).